A homogeneous immunoassay method and detection composition based on FRET
By using a composition of a bismuth-based material labeled with antigen or antibody and a rare earth doped luminescent nanocrystal, the FRET detection method is optimized, and the problems of low sensitivity and background fluorescence interference in the prior art are solved, and efficient and low-cost detection is achieved Effect.
Patent Information
- Application Number
- CN202111443663.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-11-30
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-11-30
AI Technical Summary
The existing homogeneous immunoassay method based on FRET has problems with low sensitivity and background fluorescence interference, which limits its breadth and efficiency in practical applications.
The specific binding reaction is used to detect the bismuth-based material with antigen-labeled rare earth-doped luminescent nanocrystals, or the bismuth-based material with antigen-labeled rare earth-doped luminescent nanocrystals. , optimize the molar ratio of donor to acceptor and preparation method, improve energy transfer efficiency and reliability of fluorescent signals.
It realizes the detection effect of small background fluorescence interference, high detection sensitivity, low cost and simple operation, and is suitable for rapid detection of antigens and antibodies.
Smart Images

Figure CN114137217B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of analytical chemistry, and in particular relates to a homogeneous immunoassay method and a detection composition based on FRET. The detection composition can be used for the detection of antigens and antibodies. Background Art
[0002] Homogeneous immunoassays based on fluorescence resonance energy transfer (FRET) have been a hot topic in research and application in recent years. FRET refers to the non-radiative energy transfer process between a donor and an acceptor within a certain distance (generally <10 nm). This spatial confinement effect gives FRET homogeneous detection technology many advantages, such as no need to separate and purify the analyte, simple operation, fast detection speed, good selectivity, wide application range, and simultaneous multi-component detection. It can be seen that the selection of donors and acceptors is crucial to the realization of the above-mentioned rapid and highly sensitive detection methods. For donors, rare earth doped luminescent nanocrystals (RENCs)-based donor materials have become the research frontier in the field of analytical detection. RENCs are a type of photon conversion luminescent material that is excited by near-infrared light (e.g., 980, 800 or 1530 nm) and emits from ultraviolet, visible to near-infrared bands. It has the characteristics of multi-band emission, narrow emission lines, stable photochemical properties, long fluorescence lifetime, large (anti-) Stokes shift, no photobleaching, and adjustable spectrum. Compared with traditional donor materials such as organic dyes and quantum dots, RENCs can effectively avoid biological autofluorescence and reduce scattering interference, making them an ideal donor material for constructing sensing models in complex biological matrices (blood, urine, saliva, organisms, etc.).
[0003] Although RENC-FRET-based biological detection technology has attracted great attention in recent years, it is still far from practical application due to its low detection sensitivity. According to the energy transfer formula, improving the energy transfer efficiency is to shorten the interaction distance between the donor and the acceptor on the one hand, and to improve the luminescence efficiency of the donor on the other hand. However, since RENCs are composed of rare earth ions with independent luminescence centers, and the energy transfer efficiency is inversely proportional to the sixth power of the distance, only the luminescence center located at the surface interface and close enough to the acceptor can produce FRET with the acceptor, while the internal luminescent ions do not contribute to this process. For example, in the existing co-doped system (Yb 3+ , Er 3+ )Only the surface of Er 3+Participate in energy transfer, thus seriously reducing the FRET efficiency. On the other hand, although the luminescence brightness of RENCs can be increased by increasing the thickness of the RENCs shell to suppress the surface quenching effect, it also increases the interaction distance between the donor and the acceptor, which limits the improvement of detection sensitivity. Therefore, in order to overcome the above problems, it is particularly important to develop new design ideas and new methods to develop detection applications with a wider range of applications and to construct an efficient RENC-FRET detection method with high detection sensitivity and low fluorescence background. Summary of the invention
[0004] In view of this, the object of the present invention is to provide a FRET-based homogeneous immunoassay method and a detection composition to solve the technical problems of low sensitivity and high background fluorescence in the existing FRET-based homogeneous immunoassay method.
[0005] To achieve the purpose of the present invention, the present invention adopts the following technical solution:
[0006] The present invention provides a detection composition.
[0007] It includes bismuth-based materials labeled with antigens and rare earth-doped luminescent nanocrystals labeled with antibodies;
[0008] or,
[0009] It includes bismuth-based materials labeled with antibodies and rare earth-doped luminescent nanocrystals labeled with antigens;
[0010] The antigen and antibody are an antigen-antibody pair that can undergo a specific binding reaction;
[0011] The bismuth-based material is a bismuth-based two-dimensional nanosheet material or a metal ion-doped bismuth-based two-dimensional nanosheet material.
[0012] Preferably,
[0013] The molar ratio of the bismuth-based material labeled with the antigen to the rare earth-doped luminescent nanocrystal labeled with the antibody is 1:(1-10);
[0014] The molar ratio of the bismuth-based material marked with the antibody to the rare earth-doped luminescent nanocrystal marked with the antigen is 1:(1-10).
[0015] More preferably,
[0016] The molar ratio of the bismuth-based material labeled with the antigen to the rare earth-doped luminescent nanocrystal labeled with the antibody is 1:1;
[0017] The molar ratio of the bismuth-based material labeled with the antibody to the rare earth-doped luminescent nanocrystal labeled with the antigen is 1:1.
[0018] Preferably, the bismuth-based two-dimensional nanosheet material is Bi2S3, Bi2Se3 or Bi2Te3.
[0019] Preferably,
[0020] The preparation method of the bismuth-based material labeled with an antigen is as follows:
[0021] The bismuth-based material and the solution containing the antigen are mixed overnight and then centrifuged. The obtained precipitate is dispersed in a buffer solution to obtain a solution of the bismuth-based material labeled with the antigen.
[0022] The preparation method of the bismuth-based material labeled with antibodies is as follows:
[0023] The bismuth-based material and the solution containing the antibody are mixed overnight and then centrifuged. The obtained precipitate is dispersed in a buffer solution to obtain a solution of the bismuth-based material labeled with the antibody.
[0024] Preferably,
[0025] The preparation method of the rare earth doped luminescent nanocrystals labeled with antibodies is as follows:
[0026] Rare earth doped luminescent nanocrystals are coated with carboxyl polymers, then mixed with an activator and a solution containing an antibody, reacted, centrifuged, and the obtained precipitate is dispersed in a buffer solution to obtain a solution of rare earth doped luminescent nanocrystals labeled with antibodies;
[0027] The preparation method of the rare earth doped luminescent nanocrystals labeled with antigens is as follows:
[0028] Rare earth doped luminescent nanocrystals are coated with carboxyl polymers, then mixed with an activator and a solution containing an antigen, reacted, and centrifuged. The obtained precipitate is dispersed in a buffer solution to obtain a solution of rare earth doped luminescent nanocrystals labeled with antigens.
[0029] The present invention also provides a method for performing antibody detection using the above antigen detection composition, comprising the following steps:
[0030] 1) uniformly mixing a bismuth-based material solution labeled with an antigen and a rare earth-doped luminescent nanocrystal solution labeled with an antibody to obtain a detection system;
[0031] 2) Adding a sample to be detected into the detection system and performing emission spectrum detection.
[0032] The present invention also provides a method for performing antigen detection using the above antibody detection composition, comprising the following steps:
[0033] 1) uniformly mixing a bismuth-based material solution labeled with an antibody and a rare earth-doped luminescent nanocrystal solution labeled with an antigen to obtain a detection system;
[0034] 2) Adding a sample to be detected into the detection system and performing emission spectrum detection.
[0035] Preferably, the excitation light of the emission spectrum is near-infrared light of 700 to 1700 nm, and the emission light is visible light of 400 to 800 nm or near-infrared light of 900 to 1700 nm.
[0036] More preferably, the excitation light of the emission spectrum is 800nm near-infrared light, and the emission light is 540nm visible light, 650nm visible light, 1064nm near-infrared light or 1530nm near-infrared light.
[0037] More preferably, the excitation light of the emission spectrum is 980nm near-infrared light, and the emission light is 690nm visible light, 800nm visible light, 1064nm near-infrared light, 1180nm near-infrared light or 1530nm near-infrared light.
[0038] More preferably, the excitation light of the emission spectrum is near-infrared light of 1530 nm, and the emission light is visible light of 650 nm, visible light of 800 nm or near-infrared light of 1180 nm.
[0039] Compared with the prior art, the present invention has the following beneficial effects:
[0040] The FRET-based homogeneous immunoassay method of the present invention has the advantages of small background fluorescence interference, high detection sensitivity, low cost, simple method, easy operation, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] In order to more clearly illustrate the technical solution of the present invention, the drawings required for use in the specific implementation methods will be briefly introduced below. Obviously, the drawings described below are only some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0042] Figure 1 This is a scanning electron microscope image of the bismuth-based material (Bi2Se3 nanomaterial) prepared in Example 1 of the present invention;
[0043] Figure 2 This is an absorption spectrum of the bismuth-based material (Bi2Se3 nanomaterial) prepared in Example 1 of the present invention in the visible light band;
[0044] Figure 3 is a scanning electron microscope image of RENCs prepared in Example 1 of the present invention;
[0045] Figure 4is the up-conversion emission spectrum of RENCs labeled with antibodies prepared in Example 1 of the present invention under 980nm light excitation;
[0046] Figure 5 The change in the luminescence intensity of the upconversion nanomaterial after the introduction of the antigen-modified bismuth-based material (Bi2Se3 nanomaterial) into the RENCs labeled with the antibody prepared in Example 1 of the present invention;
[0047] Figure 6 This is the change in the luminescence intensity of the up-conversion nanomaterial after an immune competition reaction is carried out by introducing free antigens in Example 1 of the present invention.
[0048] Figure 7 This is a scanning electron microscope image of RENCs prepared in Example 2 of the present invention.
[0049] Figure 8 This is the up-conversion emission spectrum of RENCs labeled with antibodies prepared in Example 2 of the present invention under 980 nm light excitation. DETAILED DESCRIPTION
[0050] In order to further understand the present invention, the preferred embodiments of the present invention are described below in conjunction with specific implementation methods, but it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention rather than limiting the patent claims of the present invention.
[0051] The present invention provides a detection composition, comprising a bismuth-based material marked with an antigen and a rare earth-doped luminescent nanocrystal marked with an antibody; or comprising a bismuth-based material marked with an antibody and a rare earth-doped luminescent nanocrystal marked with an antigen; wherein the antigen and the antibody are an antigen-antibody pair capable of undergoing a specific binding reaction.
[0052] In the present invention, there are no special restrictions on antigens and antibodies. Theoretically, any antigen-antibody pair that can undergo a specific binding reaction can be used. For example, the antigen can be a new coronavirus antigen, PSA, etc., and the antibody can be a new coronavirus antibody IgM / IgG, etc.
[0053] In the present invention, the bismuth-based material is a bismuth-based two-dimensional nanosheet material or a metal ion-doped bismuth-based two-dimensional nanosheet material. The material is a prior art and can be obtained by commercial purchase or laboratory synthesis and other means familiar to those skilled in the art. For example, the commonly used bismuth-based two-dimensional nanosheet materials are Bi2S3, Bi2Se3 or Bi2Te3, and the present invention preferably uses bismuth-based two-dimensional nanosheet materials Bi2Se3 or Bi2Te3. The doped metal ions can be rare earth ions, transition metal ions, etc., and the doping ratio is unlimited. The present invention provides a preparation method of a bismuth-based material labeled with an antigen, but is not limited thereto, specifically: the bismuth-based material is stirred and mixed with a solution containing an antigen for more than 12 hours, centrifuged, and the obtained precipitate is dispersed in a buffer solution to obtain a bismuth-based material labeled with an antigen, wherein the molar ratio of the bismuth-based material to the antigen is 1: (0.1-0.5), preferably 1: 0.2. The buffer solution is preferably a Tris hydrochloric acid buffer solution with a pH of 7.2 and a concentration of 0.05M. The present invention provides a method for preparing a bismuth-based material labeled with an antibody, but is not limited thereto, specifically: the bismuth-based material and a solution containing an antibody are stirred and mixed for more than 12 hours, centrifuged, and the obtained precipitate is dispersed in a buffer to obtain a bismuth-based material labeled with an antibody. The buffer is preferably a Tris hydrochloric acid buffer with a pH of 7.2 and a concentration of 0.05M. In the present invention, the molar ratio of the bismuth-based material to the antibody is 1:(0.1-0.5), preferably 1:0.2.
[0054] In the present invention, rare earth doped luminescent nanocrystals are prior art and can be obtained by commercial purchase or laboratory synthesis and other means familiar to those skilled in the art. Rare earth doped luminescent nanocrystals can be luminescent nanocrystals doped with one rare earth element, and the luminescent center ion is any rare earth element other than Y, Lu and Gd, such as NaErF4@NaYF4. It can also be a luminescent nanocrystal doped with a co-doping system of two or more rare earth ions, and the doping system can be Yb and Er, Yb and Tm, Yb and Nd, Yb and Ho, etc., such as NaErF4:YbEr. It can also be a core-shell structure. The present invention provides a method for preparing rare earth doped luminescent nanocrystals marked with antibodies, but is not limited thereto. Specifically, the rare earth doped luminescent nanocrystals are dissolved in a solvent (cyclohexane), precipitated with ethanol, centrifuged, and then dissolved in chloroform, a carboxyl polymer is added, the solvent is removed by rotary evaporation after being fully mixed, and the solution is dissolved in deionized water, and then mixed with an activator and a solution containing an antibody or antigen, reacted, and centrifuged. The obtained precipitate is dispersed in a buffer solution to obtain a solution of rare earth doped luminescent nanocrystals marked with antibodies or antigens. Among them, the carboxyl polymer is preferably polymethyl methacrylate grafted with octadecylamine, the grafting method is an EDC coupling method, and the modification ratio is 30-40%. The mass ratio of the rare earth doped luminescent nanocrystal to the carboxyl polymer is 1:(1-4). The activator is preferably EDC, or a mixture of EDC and NHS, and the reaction ratio of the antigen or antibody to the activator is 1:(1-5) equivalents. The molar ratio of the rare earth doped luminescent nanocrystal to the antigen or antibody is 1:(0.2-0.6), more preferably 0.4. The reaction time is preferably 3 h. The reaction method is EDC coupling method. The buffer is preferably Tris hydrochloric acid buffer.
[0055] In the present invention, the molar ratio of the bismuth-based material labeled with the antigen to the rare earth-doped luminescent nanocrystal labeled with the antibody is 1:(1-10), and the preferred molar ratio is 1:1.
[0056] In the present invention, the molar ratio of the bismuth-based material labeled with the antibody to the rare earth-doped luminescent nanocrystal labeled with the antibody is 1:(1-10), and the preferred molar ratio is 1:1.
[0057] The detection composition of the present invention can be used in a method for detecting an antigen or an antibody, comprising the following steps:
[0058] 1) uniformly mixing a bismuth-based material solution labeled with an antigen and a rare earth-doped luminescent nanocrystal solution labeled with an antibody to obtain a detection system;
[0059] 2) Add the sample to be tested into the detection system and perform emission spectrum detection.
[0060] or,
[0061] 1) uniformly mixing a bismuth-based material solution labeled with an antibody and a rare earth-doped luminescent nanocrystal solution labeled with an antigen to obtain a detection system;
[0062] 2) Add the sample to be tested into the detection system and perform emission spectrum detection.
[0063] In the present invention, the sample to be detected is an antigen or an antibody.
[0064] In the present invention, the excitation light of the emission spectrum is near-infrared light of 700 to 1700 nm, and the emission light is visible light of 400 to 800 nm or 900 to 1700 nm. Preferably, the excitation light of the emission spectrum is near-infrared light of 800 nm, and the emission light is visible light of 540 nm, visible light of 650 nm, near-infrared light of 1064 nm, or near-infrared light of 1530 nm; or, the excitation light of the emission spectrum is near-infrared light of 980 nm, and the emission light is visible light of 690 nm, visible light of 800 nm, near-infrared light of 1064 nm, near-infrared light of 1180 nm, or near-infrared light of 1530 nm; the excitation light of the emission spectrum is 1530 nm, and the emission light is visible light of 650 nm, visible light of 800 nm, or near-infrared light of 1180 nm.
[0065] The process parameters of the antigen / antibody detection method of the present invention can be appropriately improved by those skilled in the art with reference to the contents of this article.
[0066] The terms used in the present invention generally have the meanings commonly understood by those of ordinary skill in the art, unless otherwise specified.
[0067] In order to enable those skilled in the art to better understand the technical solution of the present invention, the present invention will be further described in detail below in conjunction with embodiments.
[0068] In the following examples, various processes and methods not described in detail are conventional methods known in the art. Unless otherwise specified, the materials, reagents, devices, instruments, equipment, etc. used in the following examples can be obtained from commercial sources.
[0069] Example 1
[0070] 1) Preparation of bismuth-based materials (Bi2Se3 nanomaterials)
[0071] 0.372mmolBi(NO3)3·.3H2O, 0.560mmol NaSeO3 and 0.4gPVP were placed in a 50mL three-necked bottle, and 24mL ethylene glycol was added. Then the three-necked bottle was placed in a magnetic stirring heater, and nitrogen was introduced for protection at the same time, heated to 60°C, and maintained at this temperature for 30min. After the solid was completely dissolved, a clear and transparent solution was obtained. After that, the clear and transparent solution was heated to 180°C, and a mixed solution of 0.8mL hydrazine hydrate and 8mL ethylene glycol was injected at this temperature, and the reaction was carried out for 30min. The reaction was carried out under nitrogen protection and refluxed with cooling water. After the reaction was completed, it was cooled to room temperature and purified by centrifugation with acetone once to obtain Bi2Se3 nanomaterials. The obtained Bi2Se3 nanomaterials were dispersed in 16mL deionized water for standby use.
[0072] The obtained Bi2Se3 nanomaterials were detected by scanning electron microscopy and absorption spectroscopy. Figure 1 and Figure 2 shown. Figure 1 This is a scanning electron microscope image of Bi2Se3 nanomaterials; Figure 2 This is the absorption spectrum of Bi2Se3 nanomaterials in the visible light band. Figure 1 and Figure 2 It can be seen that the obtained Bi2Se3 nanomaterial is a uniform material with a size of about 100 nm and an absorption peak at 482 nm.
[0073] 2) Preparation of RENCs
[0074] 1mmol of rare earth chloride (including 0.78mmol YCl3·6H2O, 0.20mmol YbCl3·6H2O and 0.02mmol ErCl3·6H2O) was placed in a 50mL three-necked flask, and 15mL of octadecene and 6mL of oleic acid were added. The three-necked flask was then placed in a magnetic stirring heater, and nitrogen was introduced for protection, and heated to 160°C and maintained at this temperature for 30 minutes. After the chloride was completely dissolved, a slightly light yellow clear and transparent solution was obtained. Then, the mixture was cooled to room temperature, 10 mL of methanol solution containing 4 mmol of NH4F and 2.5 mmol of NaOH was added dropwise to a three-necked flask, and then heated to 70°C for 30 min to completely evaporate the methanol in the solution. The mixture was then heated to 300°C and reacted for 90 min. During the reaction, argon was always passed for protection, and cooling water was used for reflux. After the reaction was completed, the mixture was cooled to room temperature, ethanol was added, and centrifuged for purification three times to obtain RENCs. The obtained RENCs were dissolved in 4 mL of cyclohexane for later use.
[0075] The obtained materials were examined by scanning electron microscopy. Figure 3 shown. Figure 3 This is a scanning electron microscope image of RENCs. Figure 3 It can be seen that the obtained RENCs are uniform particles with a particle size of about 20 nm.
[0076] 3) Preparation of RENCs labeled with antibodies
[0077] Take 1 mL of the cyclohexane solution of RENCs, precipitate with ethanol and centrifuge, then redissolve with chloroform, and add 50 mg of carboxyl polymer (polymethyl methacrylate grafted with octadecylamine, the grafting method is EDC coupling method, and the modification ratio is 35%), mix thoroughly and evaporate to remove the solvent, and dissolve in 2 mL of deionized water for use. Then take 0.1 mL of the obtained material aqueous solution, centrifuge to obtain upconversion nanomaterials, disperse with 1 mL Tris-HCl [pH = 7.2, 0.05 M], add 8 mg NHS, 5 mg EDC, stir thoroughly and then add 5 mg EDC and 0.4 mg goat anti-bovine serum albumin, stir for 3 hours, and centrifuge to obtain RENCs labeled with antibodies, dissolve with 2 mL Tris-HCl [pH = 7.2, 0.05 M], and set aside.
[0078] The emission spectrum of the obtained RENCs labeled with antibodies was detected by excitation light at 980 nm, and the emission spectrum in the wavelength range of 450 to 750 nm was measured as follows: Figure 4 shown. Figure 4 : is the up-conversion emission spectrum of RENCs labeled with antibodies prepared in Example 1 of the present invention under 980nm light excitation. Figure 4 It can be seen that the upconversion luminescence generated by RENCs under 980nm light excitation can match well with the absorption of Bi2Se3, which can effectively realize the energy transfer between RENCs and Bi2Se3, and then detect the corresponding biological molecules according to the changes in the fluorescence signal of RENCs.
[0079] 4) Bismuth-based materials labeled with antigens
[0080] The bismuth-based material and a solution containing an antigen (the molar ratio of the bismuth-based material to goat IgG is 1:0.2) were mixed overnight and centrifuged. The resulting precipitate was dispersed in 1 mL of Tris-HCl [pH=7.2, 0.05 M] to obtain a bismuth-based material labeled with an antigen.
[0081] 5) Antibody-labeled RENCs introduced into antigen-modified bismuth-based materials
[0082] According to the molar ratio of bismuth-based material labeled with antigen to rare earth-doped luminescent nanocrystal labeled with antibody being 1:1, the bismuth-based material solution labeled with antigen obtained in step 4) and the rare earth-doped luminescent nanocrystal solution labeled with antibody obtained in step 3) were mixed evenly to obtain a detection system. The antigen sample to be detected (sheep IgG, 40 μg / mL) was added to the detection system, and emission spectrum detection was performed. The results are as follows: Figure 5 shown.
[0083] Figure 5 is the change in the luminescence intensity of the upconversion nanomaterial after the introduction of the antigen-modified bismuth-based material into RENCs labeled with antibodies in Example 1 of the present invention; Figure 5 It can be seen that the luminescence intensity becomes weaker, indicating that energy transfer occurs between the donor and the acceptor, which comes from the specific binding of antigen / antibody.
[0084] Figure 6 The change in the luminescence intensity of the upconversion nanomaterial after the immune competition reaction was carried out by introducing a solution containing an antigen (sheep IgG, 40 μg / mL) in Example 1 of the present invention. Figure 6 It can be seen that the luminescence becomes stronger. This is because the number of donor-acceptor pairs undergoing energy transfer decreases, and the luminescence of the rare earth luminescent nanocrystals is restored.
[0085] Example 2
[0086] Steps 1), 3), 4), and 5) are the same as those in Example 1, except that step 2) in Example 1 is replaced by:
[0087] 1mmol of rare earth chloride (including 0.745mmol YCl3·6H2O, 0.25mmol YbCl3·6H2O and 0.05mmol TmCl3·6H2O) was placed in a 50mL three-necked flask, and 15mL of octadecene and 6mL of oleic acid were added. The three-necked flask was then placed in a magnetic stirring heater, and argon gas was introduced for protection, and heated to 160°C until the chloride was completely dissolved to obtain a slightly light yellow, clear and transparent solution. Then, the mixture was cooled to room temperature, 10 mL of methanol solution containing 4 mmol of NH4F and 2.5 mmol of LiOH was added dropwise to the three-necked flask, and then heated to 75°C for 30 min to completely remove the methanol in the solution. The mixture was then heated to 300°C and reacted for 1.5 h. During the reaction, argon was always passed for protection, and cooling water was used for reflux. After the reaction was completed, the mixture was cooled to room temperature, ethanol was added, and centrifuged for purification three times to obtain RENCs. The obtained RENCs were dissolved in 8 mL of cyclohexane for later use.
[0088] The obtained RENCs were detected by scanning electron microscopy. Figure 7 shown. Figure 7This is a scanning electron microscope photo of RENCs prepared in Example 2. Figure 7 It can be seen that the obtained RENCs are uniform particles with a particle size of about 25 nm.
[0089] The emission spectrum of the obtained RENCs labeled with antibodies was detected by using an excitation light of 980 nm, and the emission spectrum thereof in the wavelength range of 300 to 850 nm was measured as follows: Figure 8 As shown. Figure 8 It can be seen that the luminescence of RENCs in the near-infrared region at 800 nm is consistent with the absorption spectrum of Bi2Se3 ( Figure 2 ) have a large overlap, indicating that effective energy transfer detection applications can be carried out.
[0090] The above description of the disclosed embodiments enables one skilled in the art to implement and use the present invention. Multiple modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest range consistent with the principles and novel features disclosed herein.
Claims
1. A detection composition, characterized in that It includes bismuth-based materials labeled with antigens and rare earth-doped luminescent nanocrystals labeled with antibodies; or, It includes bismuth-based materials labeled with antibodies and rare earth-doped luminescent nanocrystals labeled with antigens; The antigen and antibody are an antigen-antibody pair that can undergo a specific binding reaction; The bismuth-based material is a bismuth-based two-dimensional nanosheet material or a metal ion-doped bismuth-based two-dimensional nanosheet material; the bismuth-based two-dimensional nanosheet material is Bi2S3, Bi2Se3 or Bi2Te3; The rare earth-doped luminescent nanocrystal is a luminescent nanocrystal doped with one rare earth element, and the luminescent center ion is any rare earth element other than Y, Lu and Gd; or, the rare earth-doped luminescent nanocrystal is a luminescent nanocrystal doped with a co-doping system of two or more rare earth ions, and the doping system is one of the following systems: Yb and Er, Yb and Tm, Yb and Nd, Yb and Ho.
2. A detection composition according to claim 1, characterized in that: The molar ratio of the bismuth-based material labeled with the antigen to the rare earth-doped luminescent nanocrystal labeled with the antibody is 1:(1-10); The molar ratio of the bismuth-based material labeled with the antibody to the rare earth-doped luminescent nanocrystal labeled with the antigen is 1:(1-10).
3. A detection composition according to claim 2, characterized in that: The molar ratio of the bismuth-based material labeled with the antigen to the rare earth-doped luminescent nanocrystal labeled with the antibody is 1:1; The molar ratio of the bismuth-based material labeled with the antibody to the rare earth-doped luminescent nanocrystal labeled with the antigen is 1:
1.
4. A detection composition according to claim 1, characterized in that: The preparation method of the bismuth-based material labeled with an antigen is as follows: The bismuth-based material and the solution containing the antigen are mixed overnight, centrifuged, and the obtained precipitate is dispersed in a buffer solution to obtain a solution of the bismuth-based material labeled with the antigen; The preparation method of the bismuth-based material labeled with antibodies is as follows: The bismuth-based material and the solution containing the antibody are mixed overnight and then centrifuged. The obtained precipitate is dispersed in a buffer solution to obtain a solution of the bismuth-based material labeled with the antibody.
5. A detection composition according to claim 1, characterized in that: The preparation method of the rare earth doped luminescent nanocrystals labeled with antibodies is as follows: Rare earth doped luminescent nanocrystals are coated with carboxyl polymers, then mixed with an activator and a solution containing an antibody, reacted, centrifuged, and the obtained precipitate is dispersed in a buffer solution to obtain a solution of rare earth doped luminescent nanocrystals labeled with antibodies; The preparation method of the rare earth doped luminescent nanocrystals labeled with antigens is as follows: Rare earth doped luminescent nanocrystals are coated with carboxyl polymers, then mixed with an activator and a solution containing an antigen, reacted, and centrifuged. The obtained precipitate is dispersed in a buffer solution to obtain a solution of rare earth doped luminescent nanocrystals labeled with antigens.
6. A method for detecting an antigen or an antibody using the detection composition according to any one of claims 1 to 5, characterized in that: The steps include: 1) Evenly mixing a bismuth-based material solution labeled with an antigen and a rare earth-doped luminescent nanocrystal solution labeled with an antibody to obtain a detection system; 2) adding a sample to be detected into the detection system and performing emission spectrum detection; or, 1) Evenly mixing a bismuth-based material solution labeled with an antibody and a rare earth-doped luminescent nanocrystal solution labeled with an antigen to obtain a detection system; 2) Adding the sample to be detected into the detection system and performing emission spectrum detection.
7. The detection method according to claim 6, characterized in that: The excitation light of the emission spectrum is near-infrared light of 700-1700 nm, and the emission light is visible light of 400-800 nm or near-infrared light of 900-1700 nm.
8. The detection method according to claim 7, characterized in that: The excitation light of the emission spectrum is 800 nm near-infrared light, and the emission light is 540 nm visible light, 650 nm visible light, 1064 nm near-infrared light or 1530 nm near-infrared light; or, The excitation light of the emission spectrum is 980 nm near-infrared light, and the emission light is 690 nm visible light, 800 nm visible light, 1064 nm near-infrared light, 1180 nm near-infrared light or 1530 nm near-infrared light; or, The excitation light of the emission spectrum is 1530 nm near-infrared light, and the emission light is 650 nm visible light, 800 nm visible light or 1180 nm near-infrared light.
